Major market opportunities in blood group typing include advancements in PCR and NGS technologies, growing demand for ...
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of ...
Pregnancy loss may occur in as many as 25% of all pregnancies. Most of these losses occur in the first trimester, and about ...
Q3 2025 Earnings Call Transcript November 13, 2025 Bionano Genomics, Inc. beats earnings expectations. Reported EPS is ...
News-Medical.Net on MSN
Uncovering hidden causes of recurrent pregnancy loss with optical genome mapping
Pregnancy loss may occur in as many as 25% of all pregnancies. Most of these losses occur in the first trimester, and about ...
The data, which is being presented at this year's AMP meeting, offers some insights into the often hidden causes of recurrent pregnancy loss.
Detailed price information for Bionano Genomics Inc (BNGO-Q) from The Globe and Mail including charting and trades.
Bionano Genomics, Inc. ( BNGO) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Good day, and welcome to the Bionano Third Quarter 2025 Earnings Conference Call. Today's conference is being ...
Researchers have created a chip that's implanted in the eye, that with the help of AR glasses, can partially restore ...
Seasoned global pharmaceutical executive, Mr Brent MacGregor, joins Vaxxas Board to accelerate self-administered HD-MAP vaccines for global ...
1don MSN
GeoVax outlines expedited GEO-MVA clinical trial and global partnership strategy for 2025-2026
Discover key insights from GeoVax Labs’ Q3 2025 earnings call—expedited vaccine trials, partnership updates & clinical progress.
A new technology may allow patients to recover vision for conditions that were previously thought irreversible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results